Search Results

KM Biologics announces promising results of Phase I clinical study of dengue vaccine KD-382

• Source: Global Banking News (GBN). 03/25/2021.

Record details

KM Biologics announces promising results of Phase I clinical study of dengue vaccine KD-382

• Source: EquityBites (M2). 03/25/2021.

Record details

Protinhi Therapeutics selected as part of BLUE KNIGHT™ collaboration for pandemic preparedness

• Authors : PR Newswire

Subjects: Netherlands

• Source: PR Newswire US. 11/16/2021.

Record details

Zika virus Infections - Pipeline Review, H1 2017

• Authors : PR Newswire

Subjects: England

• Source: PR Newswire US. 06/29/2017.

Record details

Global Hepatitis C Market 2014-2018

• Authors : PR Newswire

Subjects: England

• Source: PR Newswire US. 09/08/2014.

Record details

FDA approves additional claim for Roche cobas Zika test

• Authors : PR Newswire

Subjects: California

• Source: PR Newswire US. 05/14/2018.

Record details

bioLytical Laboratories Announces Patent Filings in U.S. for Zika Detection Assays

• Authors : Canada Newswire

Subjects: British Columbia

• Source: Canada Newswire. 08/19/2016.

Record details

Moderna Inc Corporate Analyst Meeting - Final

• Source: Fair Disclosure Wire (Quarterly Earnings Reports). 04/14/2020.

Record details

West Nile Virus Therapeutics Market 2019-2023 | Availability of Over-the-Counter (OTC) Therapeutics to Boost Growth | Technavio

• Authors : Technavio Research

• Source: Business Wire (English). 06/01/2020.

Record details

Catalent Signs Development Agreement with Ennaid Therapeutics on its COVID-19 Lead Program

• Authors : PR Newswire

Subjects: New Jersey

• Source: PR Newswire US. 05/13/2020.

Record details